Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Urolithin A is a secondary metabolite of ellagic acid, a polyphenolic antioxidant, that has antiproliferative, anti-inflammatory, and anti-oxidant properties.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 42.00 | |
10 mg | In stock | $ 66.00 | |
25 mg | In stock | $ 132.00 | |
50 mg | In stock | $ 197.00 | |
100 mg | In stock | $ 337.00 | |
200 mg | In stock | $ 497.00 | |
500 mg | Inquiry | $ 793.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 46.00 |
Description | Urolithin A is a secondary metabolite of ellagic acid, a polyphenolic antioxidant, that has antiproliferative, anti-inflammatory, and anti-oxidant properties. |
In vitro | Urolithin A decreases proliferation in ECC-1, Ishikawa, and HEC-1A human endometrial cancer cell lines at a concentration of 1 μM, arrests the cell cycle at the G2/M transition, and modulates estrogen receptor-regulated gene expression[1]. |
Molecular Weight | 228.2 |
Formula | C13H8O4 |
CAS No. | 1143-70-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 33 mg/mL (144.61 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Urolithin A 1143-70-0 Apoptosis Autophagy Cell Cycle/Checkpoint DNA Damage/DNA Repair Immunology/Inflammation Metabolism NF-Κb Reactive Oxygen Species DNA/RNA Synthesis Endogenous Metabolite Drug Metabolite Inhibitor inhibit inhibitor